LGND — Ligand Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $1.27bn
- $1.10bn
- $131.31m
- 76
- 39
- 90
- 77
Annual cashflow statement for Ligand Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 629 | -2.98 | 57.1 | -33.4 | 52.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -748 | 61 | 31.4 | 33.3 | -16.4 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.21 | -10.1 | -52.2 | 65.7 | -34.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -29.3 | 54.6 | 78.8 | 138 | 49.6 |
| Capital Expenditures | -2.55 | -4.46 | -8.76 | -17.9 | -64.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 469 | 236 | 39.3 | 182 | 52.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 467 | 232 | 30.5 | 164 | -11.7 |
| Financing Cash Flow Items | -7.42 | -3.81 | 11.9 | -18.2 | -5.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -485 | -311 | -138 | -276 | -59.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -47.5 | -24.3 | -28.4 | 25.5 | -22.1 |